Sign in

CIK 0000873303

  • Large accelerated filer

Sarepta Therapeutics, Inc.

Sign in to watch
Ticker
SRPT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
930797222
Phone
+1 617-274-4000
Business address
215 FIRST STREET, SUITE 415, CAMBRIDGE, MA, 02142
Former names
Sarepta Therapeutics, Inc., AVI BIOPHARMA INC, ANTIVIRALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-03 O'Neill Gilmore Neil EVP, R&D & CMO Grant or award +15,000 29,070
2021-03-03 O'Neill Gilmore Neil EVP, R&D & CMO Grant or award · Stock Option (right to buy) +60,000 60,000
2021-03-03 Nicaise Claude Director Grant or award +2,726 11,852
2021-03-03 Nicaise Claude Director Grant or award · Stock Option (right to buy) +5,518 5,518
2021-03-03 MARTIN JOHN C Director Grant or award +2,726 7,913
2021-03-03 MARTIN JOHN C Director Grant or award · Stock Option (right to buy) +5,518 5,518
2021-03-03 GRAY MARY ANN Director Grant or award +2,726 8,436
2021-03-03 GRAY MARY ANN Director Grant or award · Stock Option (right to buy) +5,518 5,518
2021-03-03 Estepan Ian Michael Chief Financial Officer Grant or award +15,000 29,042
2021-03-03 Estepan Ian Michael Chief Financial Officer Grant or award · Stock Option (right to buy) +60,000 60,000
2021-03-03 Ciambrone William EVP Grant or award +15,000 15,000
2021-03-03 Ciambrone William EVP Grant or award · Stock Option (right to buy) +60,000 60,000
2021-03-03 Brown Ryan Edward SVP, General Counsel Grant or award +15,000 19,838
2021-03-03 Brown Ryan Edward SVP, General Counsel Grant or award · Stock Option (right to buy) +60,000 60,000
2021-03-03 Barry Richard Director Grant or award +2,726 3,125,366
2021-03-03 Barry Richard Director Grant or award · Stock Option (right to buy) +5,518 5,518
2021-03-03 BEHRENS M KATHLEEN Director Grant or award +2,726 130,517
2021-03-03 BEHRENS M KATHLEEN Director Grant or award · Stock Option (right to buy) +5,518 5,518
2021-02-28 O'Neill Gilmore Neil EVP, R&D & CMO Shares withheld for taxes −524 $86.97 $46K 13,546
2021-02-28 Brown Ryan Edward SVP, General Counsel Shares withheld for taxes −216 $86.97 $19K 4,622

Page 21 of 22 · 424 trades